JPRN-UMIN000050595已完成Unknown
Stimulation evaluation test for people with sensitive skin of CBN serum - Stimulation evaluation test for people with sensitive skin of CBN serum
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Person who are pregnant, breastfeeding, or may become pregnant in the near future. 2. Person who have an underlying disease. 3. Person who have skin symptoms that may interfere with the ability to accurately judge discomfort such as strong sunburn, wounds, and acne at the test site by visual observation of the test investigator. 4. Person who are currently undergoing outpatient treatment for atopic dermatitis. 5. Person who currently have allergic symptoms (hay fever, allergic rhinitis, etc.). 6. Person who are currently undergoing facial skin treatment. 7. Person who have participated in other exams. 8. Person who have had fever or respiratory symptoms in themselves or a family member living with them during the two weeks before the start date of the measurement, or those who have been in close contact with a person infected with the new coronavirus. 9. Person who plan or wish to be vaccinated against the new coronavirus infection from 2 weeks before the study participation to the end of the study. 10. Person who are wearing pacemakers and implantable spinal cord stimulators. 11. Person who are judged by the principal investigator or the person in charge of conducting the study to be inappropriate.
研究者
相似试验
已完成
不适用
Human Repeat Insult Patch TestingCTRI/2019/09/021426The Himalaya Drug Company345
已完成
不适用
Evaluation of the Sensorineural Acuity Level test as a diagnostic test for triage purposeshearing losshearing impaired10019243NL-OMON33206Stichting Audicienregister200
尚未招募
不适用
A study to look at a new way of detecting the spread of pancreas cancer.ACTRN12617000595314Royal Brisbane and Women's Hospital24
已完成
1 期
To evaluate the safety of test products.CTRI/2020/03/023725The Himalaya Drug Company200
已完成
1 期
To study the safety of test products on the skin.CTRI/2020/06/026085The Himalaya Drug Company200
